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Abstract 
Primary mediastinal B-cell lymphoma (PMBL) and nodular sclerosis classic Hodgkin 
lymphoma (NSCHL) share common clinical, histological and molecular features which 
often result in differential diagnosis complications. Given the high importance of the 
tumor microenvironment (TME) in lymphomas, we aimed to investigate if the 
aforementioned similarities reflect the cellular composition of their immune milieu as 
well. Twenty-four mediastinal mass biopsies (12 PMBL cases and 12 NSCHL cases) 
from previously untreated patients were re-evaluated and examined for the infiltration 
levels by eosinophils, mast cells, CD4+ T cells, CD8+ T cells and FOXP3+ cells. NSCHL 
cases were statistically significantly infiltrated in higher levels by all of the examined 
cells, apart from CD8+ T cells, which were found more abundant in PMBL. Of note, 2 
out of 12 PMBL cases presented FOXP3 positivity of the neoplastic cells. The TME of 
NSCHL was found more abundant and heterogeneous compared to that of PMBL, 
which should be taken into account in the differential diagnosis. Moreover, FOXP3 
scarcity in PMBL suggests different mechanisms for T-cell anergy induction.  
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Primary mediastinal B-cell lymphoma 
(PMBL) was originally described in 
1980 (Lichtenstein et al., 1980). The 
World Health Organization, based on 
its distinct clinical and 
immunophenotypical characteristics, 
recognizes it as a discrete entity since 
2008 and although initially described as 
a subtype of diffuse large B-cell 
lymphoma (DLBCL), PMBL is more 
akin to nodular sclerosis classic 
Hodgkin lymphoma (NSCHL) 
(Swerdlow et al., 2008). Their 
overlapping features may imply a 
common pathogenetic pathway and can 
often pose a diagnostic challenge. 
PMBL and NSCHL typically affect 
young women and 80% of NSCHL 
cases are located in the mediastinum 
(Traverse-Glehen et al., 2005). They 
presumably arise from thymic B cells 
and somatic hypermutations (SHM) are 
found in both neoplasms (Dunleavy and 
Wilson, 2014; Mulder et al., 2019). 
PMBL and NSCHL also share common 
genetic alterations, like 2p and 9p 
chromosome gains, having an impact 
on both neoplastic cell behavior and 
microenvironment modulation. 
Specifically, 2p chromosome gains 
result to REL locus amplification, 
leading to NF-κB activation and 
apoptotic resistance (Lees et al., 2019). 
Moreover, 9p chromosome gains, 
which are characteristic for the two 
lymphoma subtypes, result to JAK2 
amplification and consequently to 
STAT6 activation (Lees et al., 2019; 
Owen, Brockwell and Parker, 2019). 
Neoplastic cells are able of shaping the 
composition of their microenvironment, 
servicing their need for survival and 
immune escape. Cells infiltrating the 
tumor microenvironment (TME) are no 
more considered as bystanders, but as 
active participants modifying the 
progression of the disease (Mulder et 
al., 2019). The microenvironment of B-
cell lymphomas consists of various 
immune cells, stromal cells, 
extracellular matrix, blood vessels and 
connective tissue. Neoplastic B-cells 
are able to communicate and form their 
microenvironment by expressing 
numerous receptors and ligands on their 
surface and by secreting cytokines 
(Scott and Gascoyne, 2014). Taking 
that these two types of mediastinal 
lymphomas have common pathogenetic 
mechanisms, which influence their 
microenvironment, we investigated and 
compared the cellular components of 
their immune milieu. 
 
Patients and Methods 
Twenty-four cases of previously 
untreated patients presenting with a 
mediastinal mass were retrieved from 
the archives of our Department of 
Pathology. More specifically, 12 cases 
regarded PMBLs and 12 regarded 
mediastinal NSCHLs. Both 
hematoxylin and eosin (H&E) stained 
sections and the corresponding paraffin 
blocks were retrieved. H&E sections 
were re-examined, and representative 
areas of lymphoma were marked for 
tissue microarrays (TMAs) 
construction. The tissue arraying 
instrument used was Beecher 
Instruments, Silver Springs, MD. 
Cylindrical tissue cores, measuring 1.5 
mm in diameter, were extracted from 
the marked areas of each donor paraffin 
block and re-embedded into a recipient 
block at defined array coordinates. Two 
tissue cores were extracted from each 
case. Cores from thyroid, leiomyoma, 
parotid gland pleomorphic adenoma 
and colorectal adenocarcinoma were 
included in the TMA block for section 
orientation and as negative and positive 
immunostaining controls. Two TMAs 
were constructed in total, one including 
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the PMBL cases and one including the 
NSCHL cases. Firstly, TMA sections 
were stained with H&E and eosinophil 
densities for each core were evaluated 
(total eosinophil number/1.77 mm2). 
Subsequently, 3 μm unstained paraffin 
sections were cut on positively charged 




IHC was used to identify mast cells, T4, 
T8 and FOXP3+ cells, representing 
mostly the T regulatory cells (Tregs). 
IHC was performed on TMA slides 
using two methods. Dako Autostainer 
was used for CD8 and mast cell tryptase 
with the automated method EnVisionTM 
FLEX, High pH, (Link). Leica Vision 
Biosystems Bond immunostainer was 
used for CD4 and FOXP3 with the 
automated method BondTM Polymer 
Refine Detection. The antibodies and 
detection kits used are listed in Table 1. 
The slides were counterstained with 
hematoxylin, coverslipped and 
examined by light microscopy. Mast 
cell density was evaluated for each core 
using tryptase (total mast cell 
number/1.77 mm2). CD4+ T-cell 
percentage and CD8+ T-cell percentage 
was evaluated and the CD4+/CD8+ ratio 
was estimated. The percentage of 
FOXP3+ cells of total immune cells in 
each core was calculated for the 
reactive T, possibly regulatory cells. 
The mean values of each estimated 
marker from the two cores were 
calculated in each case. 
 
Statistical analysis 
The statistical analysis was performed 
using IBM SPSS Statistics 25. We 
examined the correlation status between 
eosinophilic infiltration density, mast 
cells infiltration density, CD4+/CD8+ 
ratio and FOXP3+ Tregs, using 
Spearman's rank correlation coefficient. 
In addition, we examined the 
correlation of all of the above results 
between the two groups of lymphoma 
using Mann-Whitney U Test. Non-
parametric tests were chosen due to the 
small number of cases. All variables 
apart from diagnosis were considered as 
continuous and P values <0.05 were 




immunohistochemical re-evaluation of 
the 24 cases confirmed the diagnosis of 
PMBLs in 12 cases and mediastinal 
NSCHLs in the remaining 12 (Figure 
1). The average age of diagnosis for the 
PMBL patients (7 males, 5 females) 
was 38 years and for the NSCHL 
patients (6 males, 6 females) 33 years.  
Mast cells were morphologically ovoid 
or spindle-shaped. In three cases, they 
formed small clusters. Mast cell 
infiltration density in NSCHL (number 
of mast cells/1.77 mm2) had a median 
value of 6.91/mm2 (range: 1.29-191.5) 
whereas in PMBL had a median value 
of 1.4/mm2 (0-3.10). The median 
eosinophilic infiltration density 
(eosinophils/1.77 mm2) was 12.53/mm2 
(0-157) in NSCHL, whereas no 
eosinophils were found in PMBL. CD4+ 
cells were, as expected, high in NSCHL 
and significantly lower in PMBL. CD8+ 
cells were the predominant cell type in 
the PMBL reactive microenvironment. 
FOXP3+cells were nearly absent in 
PMBL, ranging from 0 to 5% of total 
immune cells, but higher in NSCHL, 
ranging from 1 to 20%. Finally, in 2 out 
of 12 (16,6%) PMBL cases, the 
neoplastic B cell population showed 
moderate to strong nuclear 
immunoreactivity to FOXP3 antibody 
(Figure 2). 
Regarding to the statistical analysis 
results, the eosinophilic infiltration 
density, mast cell infiltration density, 
CD4+/CD8+ lymphocytic ratio, CD4+ 
and FOXP3+ cell counts were all found 
to be significantly higher in NSCHL 
compared to PMBL (p<0,05) (Figure 
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3). In the NSCHL group, FOXP3+ cells 
were negatively associated with the 
eosinophilic infiltration density (r=-
0.676, p<0.05). In the PMBL group, 
CD4+ cells were positively correlated to 
FOXP3+ cells (r=0.914, p<0.01).  
 
 
 Table 1: Antibodies used for paraffin section immunohistochemistry 
Antibody Clone Company Dilution 
CD4 NCL-CD4-1F6 Novocastra, 
Newcastle, UK 
1:50 
CD8 C8/144B Dako, Glostrup, 
Denmark 
1:70 









   








Figure 1: Hematoxylin and eosin sections of a NSCHL case (a), compared to a 










Figure 2: Representative PMBL case with FOXP3 positive neoplastic B-cells 





























Figure 3:  Comparative immunohistochemical evaluation of a NSCHL case and a 
PMBL case. The percentage of CD4+ cells is higher in NSCHL (a) compared to 
PMBL (b), whereas CD8+ cells are fewer in NSCHL (c) compared to PMBL (d). 
FOXP3+ T-cell percentage is higher in NSCHL (e) and extremely low in PMBL (f). 
Mast cell infiltration density is also higher in NSCHL (g) compared to PMBL (h) (a, 
b: CD4, 40x objective, c, d: CD8, 40x objective, e, f: FOXP3, 40x objective, g, h: 
mast cell tryptase, 40x objective) 




In this study, the TME of mediastinal 
NSCHL proved to be more abundant 
and heterogeneous than that of PMBL, 
something already known for NSCHL, 
irrespective of the site of lymphoma 
involvement. CD4+ T-cells 
outnumbered CD8+ T-cells in NSCHL. 
As already mentioned, HRS cells have 
a great dependency on CD4+ T-cells 
which exhibit a Th1 phenotype 
(Greaves et al., 2013). They are 
attracted in the TME by CCL5, CCL17, 
and CCL22 cytokines produced by the 
HRS cells (Wein and Küppers, 2016). 
On the other hand, in PMBL T 
cytotoxic cells are more abundant, 
albeit non-functional. This T- cell 
anergy could not be monitored by 
Tregs, taken into consideration the 
absence or scarcity of FOXP3+ cells in 
PMBL microenvironment, a finding 
that further reinforces the role of other 
mechanisms of immune tolerance, such 
as deregulation of immune checkpoint 
systems.  
Regarding eosinophils and mast cells, 
we confirmed that they are more 
abundant in NSCHL than in PMBL. 
High infiltration by tumor-associated 
mast cells is characteristic for the 
NSCHL (Andersen et al., 2016). In 
CHL, mast cells and eosinophils 
facilitate the tumor growth. They 
express the CD30-L on their surface 
and by activating TRAF2 and 
consequently the NF-κB pathway, urge 
CD30+ RS cells to differentiation 
(Glimelius et al., 2011). In contrast, we 
found that eosinophils were globally 
absent in PMBL.  There are no reported 
studies examining mast cell presence in 
TME of PMBL. In both CHL and 
DLBCL, mast cell infiltration is 
associated with fibrosis (Fukushima et 
al., 2006; Hedström et al., 2007; 
Nakayama et al., 2016). TME has a vital 
role in CHL, as Reed-Sternberg (RS) 
cells are highly dependent on it 
(Küppers, 2009). Indicative of the 
major role that TME has on CHL, is the 
prognostic value of PET-CT, which 
seems to be more related to 18F‐fluoro‐
deoxyglucose (18F‐FDG) uptake by 
TME ingredients, rather than neoplastic 
cells (Venkataraman et al., 2014; 
Mottok and Steidl, 2018). Our 
knowledge about the TME of PMBL is 
by far more restricted. Just like HRS 
cells, malignant B cells in B-NHLs 
depend on their TME for growth signals 
(Menter and Tzankov, 2019). Despite 
the aforementioned similarities of these 
two types of lymphoma, the results of 
the present study highlight striking 
differences in the composition of their 
microenvironment. The TME of PMBL 
bears resemblance to the TME of 
DLBCL rather than that of NSCHL.  
Finally, it is presently well known that 
FOXP3 is not solely expressed in the T 
cell linage as originally thought, but in 
various normal and cancer cells too. 
Karanikas et al. have shown FOXP3 
positivity in 25 cancer lines of both 
hematopoietic and non-hematopoietic 
tissue origin (lung, breast and colon 
cancer, melanoma, erythroid leukemia 
and acute T cell leukemia) (Karanikas 
et al., 2008), whose clinical significance 
is yet to be established. While a review 
by Triulzi et al. tends to associate tumor 
cell FOXP3 positivity with a poorer 
prognosis, mainly via mechanisms that 
promote metastatic spreading (Triulzi et 
al., 2013), there are reports claiming 
both a protective (Wang et al., 2009) 
and a favorable prognostic role (Won et 
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al., 2017). These discrepancies may be 
partially explained by the different 
antibody clones and 
immunohistochemical protocols that 
have been used. To the best of our 
knowledge, there is no previous report 
of FOXP3 positive neoplastic cells in 
B-cell lymphomas. 
Conclusively, the observed differences 
in the cellular composition of TME 
between PMBL and NSCHL could be 
of help in histopathological differential 
diagnosis, in association with other 
morphological and 
immunohistochemical features. 
FOXP3+ cells are rare in the PMBL 
immune milieu and could not be 
responsible for the induction of the 
anergic state in T cells. Moreover, as 
TME of PMBL is less studied, further 
investigations in larger cohorts are 
needed to better understand the role of 
the immune milieu on immune escape, 
its clinical or therapeutic impact, and 
possibility to become the springboard 
for developing new therapeutic targets. 
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